term=MRT2359&draw=2&rank=1 [7] https://www.bayer.com/media/en-us/bayer-to-present-latest-research-across-its-advancing-oncology-portfolio-at-aacr-2023-annual-meeting/ [8] https://clinicaltrials.gov/ct2/results?cond=&term=BAY+29655...
term=MRT2359&draw=2&rank=1 [7]https://www.bayer.com/media/en-us/bayer-to-present-latest-research-across-its-advancing-oncology-portfolio-at-aacr-2023-annual-meeting/ [8]https://clinicaltrials.gov/ct2/results?cond=&term=BAY+2965501&cntry=&state=&city=&dist= [9]https://www.abstractsonl...
1. Zhou Q, Xu C, Yang N, et al. Phase 1 study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors: updated results. Presented at: 2023 AACR Annual Meeting; April 14-19, 2023; Orlando, FL...
[3]Nurix TherapeuticsPresents Data at theAmericanAssociation for Cancer Research (AACR) Annual Meeting Highlighting Activity of its BTK Targeted Protein Degraders, NX-2127 and NX-5948, against a Broad Range of BTKi Resistance Mutations. Retrieved April 19, 2023, from网页链接 [4] OrumTherapeuticsUnv...
[7] AFFIMED PRESENTS FINAL DATA DEMONSTRATING SAFETY AND EFFICACY OF AFM13 PHASE 2 REDIRECT STUDY IN PATIENTS WITH HEAVILY PRETREATED RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2023. Retrieved April 17, 2023, from https://www.aff...
2023年4月21日,北京 安捷伦科技公司(纽约证交所:A)近日在美国癌症研究协会年会(American Association for Cancer Research Annual Meeting,简称AACR)上隆重推出了全新细胞分析、基因组学、数字病理学和伴随诊断解决方案。AACR 2023于4月14日至19日在美国佛罗里达州奥兰多举行。
百奥赛图参加了2023年4月14-19日在美国佛罗里达州奥兰多市举行的2023年美国癌症研究协会(AACR)年会,并以25张海报的形式公布了多个全人抗体平台、全人单抗药物、全人双抗ADC药物和多项临床前动物模型的最新研究成果。同时,百奥赛图团队还在展台#723与参会来宾进行了现场交流。
[1]XS-04: A first-in-class dual IRAK4/BTK inhibitor for the treatment of hematological malignancies From AACR Annual Meeting 2023 Itinerary Planner | Presentation (abstractsonline.com) [2]Discovery of a novel and oral CHK1 inhibitor for the treatment of solid tumors (abstractsonline.com. From...
AACR 2023年会将于4月14日至4月19日在美国佛罗里达州奥兰多市举行。更多信息请访问AACR大会官网：https://www.aacr.org/meeting/aacr-annual-meeting-2023/ 关于加科思 加科思药业（1167.HK）致力于为患者提供突破性治疗方案。公司在研项目围绕KRAS、肿瘤免疫、肿瘤代谢、P53、RB、MYC六大肿瘤信号通路布局，核心项目以...
AACR ANNUAL MEETING 2023April 14-19, 2023 Orange County Convention Center, 9800 International Dr, Orlando, FL 32819, US Insilico Medicine Presents Four Posters featuring AI-Designed Anti-Cancer Drugs at AACR Insilico will present four novel inhibitors for the treatment of cancer developed with its...